TIMBI WEST: Open Payments
NPI 1508853466 · CHARLESTON, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$429 in 16 payments from 9 companies in 2025. Trend: 2023 $646 · 2024 $563 · 2025 $429
Food & beverage: $429
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $168 |
| Otsuka America Pharmaceutical, Inc. | 3 | $73 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $43 |
| PFIZER INC. | 2 | $41 |
| Lilly USA, LLC | 2 | $37 |
| Antares Pharma, Inc. | 1 | $24 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Amgen Inc. | 1 | $14 |
| Exact Sciences Corporation | 1 | $14 |
Products named: BREZTRI, REXULTI, XIFAXAN, NURTEC ODT, AIRSUPRA, XYOSTED, ZEPBOUND, MOUNJARO.
Industry payments across AR — which companies pay providers there.
